Press Releases :: Avalo Therapeutics, Inc. (AVTX)

Press Releases

Dec 7, 2023

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

Nov 9, 2023

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

Oct 31, 2023

Avalo Completes Divestiture of AVTX-800 Series

Sep 26, 2023

Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation

Sep 12, 2023

Avalo Enters into Agreement to Divest AVTX-800 Series

Sep 6, 2023

Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 3, 2023

Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates

Jul 6, 2023

Avalo to Participate in SVB Securities Therapeutics Forum

Jun 26, 2023

Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthma

Jun 1, 2023

Avalo to Present at the Jefferies Healthcare Conference